Skip to main content
Signal8

Johnson Marvin

SEC insider (Form 3/4/5 filer). CIK 0001852752. Director at MARINUS PHARMACEUTICALS, INC. (MRNS). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2025. Located in RADNOR, PA.

Companies Johnson Marvin has filed insider reports for

  • MARINUS PHARMACEUTICALS, INC. (MRNS): Director
Johnson Marvin profile photo

Johnson Marvin

CIK: 0001852752

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MARINUS PHARMACEUTICALS, INC. logo
MRNS

MARINUS PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • MARINUS PHARMACEUTICALS, INC. logo
    MRNS

    MARINUS PHARMACEUTICALS, INC.

    Feb 11, 2025
    Disposition
    Direct
    7.1K shares at avg. $0.55$4K
  • MARINUS PHARMACEUTICALS, INC. logo
    MRNS

    MARINUS PHARMACEUTICALS, INC.

    Feb 7, 2025
    Disposition
    Direct
    5.4K shares at avg. $0.55$3K
  • MARINUS PHARMACEUTICALS, INC. logo
    MRNS

    MARINUS PHARMACEUTICALS, INC.

    Jan 21, 2025
    Sale
    Direct
    1.6K shares at avg. $0.54$869.4

1-3 of 3